Quantib
- Company typePrivate
- Founded2013
- HeadquartersRotterdam, Netherlands
- Headcount11–50
- GTM typeB2B
- OfferingSoftware
What Quantib does
Quantib BV is a Netherlands-based healthcare AI company that develops machine learning software for the automated analysis of medical imaging data, primarily MRI and CT scans. Founded in 2013 as a spin-off of Erasmus MC in Rotterdam, the company built a portfolio of FDA-cleared and CE-marked products, including Quantib Prostate for AI-assisted prostate cancer detection compatible with leading fusion biopsy systems, and Quantib ND / Quantib Brain for brain atrophy quantification and white matter hyperintensities detection in neurodegenerative disease assessment. The underlying technology applies advanced computer vision and anomaly detection techniques to detect tissue changes earlier than manual visual review, shortening diagnosis workflows and improving objectivity for radiologists. Distribution historically ran through direct enterprise sales to healthcare institutions and radiology departments across Europe and the United States.
In 2022, Quantib was acquired by RadNet, Inc. (NASDAQ: RDNT), a major US outpatient diagnostic imaging provider, and in 2023 was integrated into DeepHealth, RadNet's AI-powered health informatics portfolio. Under DeepHealth, the original Quantib products have been rebranded as DeepHealth Prostate and DeepHealth Brain and are sold alongside a broader suite of enterprise imaging (Diagnostic Suite, Operations Suite, TechLive) and population health (Breast, Chest, Neuro, Thyroid) solutions. Quantib BV continues to manufacture the prostate and brain products for DeepHealth Inc., operating as a wholly-owned subsidiary under RadNet's ownership. Revenue model and pricing are not publicly disclosed, but the product is positioned as a regulated medical device sold to enterprise healthcare buyers globally.
Quantib firmographics
Firmographics- Name
- Quantib
- Legal name
- Quantib BV
- Website
- https://quantib.com
- Company type
- Private
- Founded year
- 2013
- Operating status
- Acquired
- Headcount range
- 11–50 employees
- Ownership category
- akta.pro rank
Quantib industry classification
Industry- Product category
- Radiology AI Software
- NAICS
- Analytical Laboratory Instrument Manufacturing (334516)
- SIC
- Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Radiology AI, CAD & Advanced Visualization Software (HLAHABAJ)
- akta.pro secondary industries
- AI Orchestration & Imaging Analytics Platforms (Model Management/Triage) (HLACALAG), Medical Imaging AI (HDAAAEAH)
Keywords
Where Quantib is headquartered
LocationHeadquarters
- HQ city
- Rotterdam
- HQ country
- Netherlands
- HQ region
- Europe
Markets served
Quantib business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure
Distribution channels1 record
Quantib product offering
Product offeringCore offering
Quantib develops AI-powered medical imaging analysis software that automatically analyzes MRI and other diagnostic scans to detect tissue changes earlier than visual inspection. Its products focus on prostate cancer detection (Quantib Prostate, now DeepHealth Prostate) and neurodegenerative disease assessment including brain atrophy quantification and white matter hyperintensities detection (Quantib ND/Brain, now DeepHealth Brain). The software is FDA-cleared and CE-marked for clinical use.
Product overview
Quantib, now integrated into DeepHealth, was a platform of AI-powered medical imaging analysis solutions. The original product portfolio included Quantib Prostate, Quantib ND, and Quantib Brain, which have been rebranded as DeepHealth Prostate and DeepHealth Brain under the DeepHealth umbrella. DeepHealth operates as a unified AI-powered health informatics platform with Enterprise Imaging products (Diagnostic Suite™, Operations Suite™, TechLive™) and Population Health solutions (Breast Suite, Prostate Suite, Chest Suite, Neuro Suite, Thyroid Suite). Quantib's core technology used advanced machine learning for automatic analysis of medical imaging data, particularly MRI scans, enabling earlier tissue change detection than manual review.
Differentiator
Problem solved
Functional benefit
Brands
- Quantib Prostate: AI-powered prostate cancer detection solution, now integrated into DeepHealth Prostate
- Quantib ND
- Quantib Brain
Products and services
- Quantib Prostate (DeepHealth Prostate) AI-powered prostate cancer detection solution compatible with leading fusion biopsy systems. End-to-end AI-powered solution that streamlines workflow integration, automates mundane tasks, and decreases clicks for radiologists.
- Quantib Brain (DeepHealth Brain) AI-powered clinical imaging solution for brain atrophy quantification and white matter hyperintensities (WMH) detection. Assesses and monitors neurodegenerative changes with quantitative and reference data for radiologists and neurologists.
- Quantib ND Neurodegenerative disease assessment solution for brain imaging analysis, providing population health tools for assessing and monitoring neurodegenerative changes.
Companies that use Quantib
Customer profileSegments1 record
Ideal customer profiles1 record
Quantib technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability3 records
Feature3 records
Quantib partnerships and signals
Strategic signalRecent moves7 records
Expansion highlights4 records
Quantib competitors and assessment
Company assessmentMarket position
Competitive moat4 records
Key risks5 records
Key highlights6 records
Customer concentration
Quantib social profiles
Digital presenceQuantib financial estimates
Financial estimateRevenue estimate
Valuation estimate
Quantib leadership team
Management profileNumber of profiles
Profiles3 records
Quantib funding detail
Funding detailFunding overview
Funding rounds2 records
Investors3 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Quantib M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Quantib
What does Quantib do?
Quantib develops AI-powered medical imaging analysis software that automatically analyzes MRI and other diagnostic scans to detect tissue changes earlier than visual inspection. Its products focus on prostate cancer detection (Quantib Prostate, now DeepHealth Prostate) and neurodegenerative disease assessment including brain atrophy quantification and white matter hyperintensities detection (Quantib ND/Brain, now DeepHealth Brain). The software is FDA-cleared and CE-marked for clinical use.
Is Quantib a public or private company?
Quantib is a private company. It is classified as corporate owned and is currently acquired.
When was Quantib founded?
Quantib was founded in 2013. It employs 11 to 50 people.
Where is Quantib based?
Quantib is headquartered in Rotterdam, Netherlands, in the Europe region.
Does Quantib have an API?
No public API is recorded for Quantib.
What industry is Quantib in?
Quantib's product category is Radiology AI Software. Its primary akta.pro industry code is HLAHABAJ, Radiology AI, CAD & Advanced Visualization Software, with a secondary code of HLACALAG, AI Orchestration & Imaging Analytics Platforms (Model Management/Triage). Its NAICS code is 334516 and its SIC code is 3841.